Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: results from the randomized phase 3 CELESTIAL trial
ONCOLOGY RESEARCH AND TREATMENT, vol.41, pp.254, 2018 (SCI-Expanded, Scopus)
- Publication Type: Article / Abstract
- Volume: 41
- Publication Date: 2018
- Journal Name: ONCOLOGY RESEARCH AND TREATMENT
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.254
- Trakya University Affiliated: Yes